{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:36:35Z","timestamp":1789616195989,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05971-0","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T02:31:53Z","timestamp":1782354713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Puerarin as a Modulator of Synaptic Plasticity: Molecular Mechanisms Underlying Learning and Memory Restoration in Neurodegenerative Disorders"],"prefix":"10.1007","volume":"63","author":[{"given":"Xiuming","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingquan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"5971_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/361031a0","volume":"361","author":"TV Bliss","year":"1993","unstructured":"Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31\u201339","journal-title":"Nature"},{"key":"5971_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/sj.npp.1301559","volume":"33","author":"A Citri","year":"2008","unstructured":"Citri A, Malenka RC (2008) Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology 33:18\u201341","journal-title":"Neuropsychopharmacology"},{"key":"5971_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298:789\u2013791","journal-title":"Science"},{"key":"5971_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrn1809","volume":"7","author":"SN Burke","year":"2006","unstructured":"Burke SN, Barnes CA (2006) Neural plasticity in the ageing brain. Nat Rev Neurosci 7:30\u201340","journal-title":"Nat Rev Neurosci"},{"key":"5971_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nrn3200","volume":"13","author":"JH Morrison","year":"2012","unstructured":"Morrison JH, Baxter MG (2012) The ageing cortical synapse: hallmarks and implications for cognitive decline. Nat Rev Neurosci 13:240\u2013250","journal-title":"Nat Rev Neurosci"},{"key":"5971_CR6","doi-asserted-by":"crossref","unstructured":"Sheng M, Sabatini BL, S\u00fcdhof TC (2012) Synapses and Alzheimer's disease. Cold Spring Harb Perspect Biol:4","DOI":"10.1101\/cshperspect.a005777"},{"key":"5971_CR7","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S1474-4422(06)70600-7","volume":"5","author":"P Calabresi","year":"2006","unstructured":"Calabresi P, Picconi B, Parnetti L, Di Filippo M (2006) A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. Lancet Neurol 5:974\u2013983","journal-title":"Lancet Neurol"},{"key":"5971_CR8","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/ptr.5083","volume":"28","author":"YX Zhou","year":"2014","unstructured":"Zhou YX, Zhang H, Peng C (2014) Puerarin: a review of pharmacological effects. Phytother Res 28:961\u2013975","journal-title":"Phytother Res"},{"key":"5971_CR9","doi-asserted-by":"crossref","unstructured":"Yu CC, Du YJ, Li J, Li Y, Wang L, Kong LH,\u00a0Zhang Y-W\u00a0(2022) Neuroprotective mechanisms of puerarin in central nervous system diseases: update. Aging Dis 13:1092\u20131105","DOI":"10.14336\/AD.2021.1205"},{"key":"5971_CR10","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jep.2017.07.030","volume":"209","author":"MMH Bhuiyan","year":"2017","unstructured":"Bhuiyan MMH, Haque MN, Mohibbullah M, Kim YK, Moon IS (2017) Radix Puerariae modulates glutamatergic synaptic architecture and potentiates functional synaptic plasticity in primary hippocampal neurons. J Ethnopharmacol 209:100\u2013107","journal-title":"J Ethnopharmacol"},{"key":"5971_CR11","doi-asserted-by":"crossref","unstructured":"Zhao J, Cheng YY, Fan W, Yang CB, Ye SF, Cui W,\u00a0Wei W, Lao L-X\u00a0et al (2015) Botanical drug puerarin coordinates with nerve growth factor in the regulation of neuronal survival and neuritogenesis via activating ERK1\/2 and PI3K\/Akt signaling pathways in the neurite extension process. CNS Neurosci Ther 21:61\u201370","DOI":"10.1111\/cns.12334"},{"key":"5971_CR12","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.4314\/tjpr.v20i7.12","volume":"20","author":"R Liu","year":"2021","unstructured":"Liu R, Li Y, Wang Z, Li J, Liang Y, Li M (2021) Puerarin mitigates symptoms of depression in ovariectomized female rats by regulating hippocampal cAMP-CREB-BDNF signaling pathway. Trop J Pharm Res 20:1403\u20131409","journal-title":"Trop J Pharm Res"},{"key":"5971_CR13","doi-asserted-by":"publisher","first-page":"1022053","DOI":"10.3389\/fphar.2022.1022053","volume":"13","author":"Q Wang","year":"2022","unstructured":"Wang Q, Shen ZN, Zhang SJ, Sun Y, Zheng FJ, Li YH (2022) Protective effects and mechanism of puerarin targeting PI3K\/Akt signal pathway on neurological diseases. Front Pharmacol 13:1022053","journal-title":"Front Pharmacol"},{"key":"5971_CR14","doi-asserted-by":"crossref","unstructured":"Zhu G, Wang X, Chen Y, Yang S, Cheng H, Wang N,\u00a0Li Q\u00a0(2010) Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease. Planta Med 76:1820\u20131826","DOI":"10.1055\/s-0030-1249976"},{"issue":"11","key":"5971_CR15","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.3390\/antiox11112121","volume":"11","author":"D Wang","year":"2022","unstructured":"Wang D, Bu T, Li Y, He Y, Yang F, Zou L (2022) Pharmacological activity, pharmacokinetics, and clinical research progress of puerarin. Antioxidants (Basel) 11(11):2121","journal-title":"Antioxidants (Basel)"},{"key":"5971_CR16","doi-asserted-by":"crossref","unstructured":"Li P, Bai J, Dong B, Lu Y, Zhang S, Guo S,\u00a0Tan N, Zhao M\u00a0et al (2017) In vivo pharmacokinetics of puerarin via different drug administration routes based on middle cerebral artery occlusion model. Eur J Drug Metab Pharmacokinet 42:719\u2013727","DOI":"10.1007\/s13318-016-0388-4"},{"key":"5971_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/jbt.21736","volume":"30","author":"X Zhu","year":"2016","unstructured":"Zhu X, Wang K, Zhang K, Lin X, Zhu L, Zhou F (2016) Puerarin protects human neuroblastoma SH-SY5Y cells against glutamate-induced oxidative stress and mitochondrial dysfunction. J Biochem Mol Toxicol 30:22\u201328","journal-title":"J Biochem Mol Toxicol"},{"issue":"4","key":"5971_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4238\/gmr.15047501","volume":"15","author":"M Jiang","year":"2016","unstructured":"Jiang M, Yun Q, Niu G, Gao Y, Shi F, Yu S (2016) Puerarin prevents inflammation and apoptosis in the neurocytes of a murine Parkinson\u2019s disease model. Genet Mol Res 15(4):1\u20139","journal-title":"Genet Mol Res"},{"key":"5971_CR19","first-page":"1","volume":"37","author":"XH Xu","year":"2002","unstructured":"Xu XH, Zhang ZG (2002) Effect of puerarin on learning-memory behavior and synaptic structure of hippocampus in the aging mice induced by D-galactose. Yao xue xue bao = Acta Pharm Sin 37:1\u20134","journal-title":"Yao xue xue bao = Acta Pharm Sin"},{"key":"5971_CR20","first-page":"587","volume":"23","author":"XH Xu","year":"2002","unstructured":"Xu XH, Zhao TQ (2002) Effects of puerarin on D-galactose-induced memory deficits in mice. Acta Pharmacol Sin 23:587\u2013590","journal-title":"Acta Pharmacol Sin"},{"key":"5971_CR21","doi-asserted-by":"crossref","unstructured":"Li X, Ma J, Xu J, Zhu D, Li A, Che Y,\u00a0Chen D, Feng XZ\u00a0(2017) Puerarin and amlodipine improvement of D-galactose-induced impairments of behaviour and neurogenesis in mouse dentate gyrus: correlation with glucocorticoid receptor expression. Neurochem Res 42:3268\u20133278","DOI":"10.1007\/s11064-017-2366-x"},{"key":"5971_CR22","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1007\/s10753-025-02274-9","volume":"48","author":"S Lin","year":"2025","unstructured":"Lin S, Cheng Y, Cui T, Yang F, Yang S, Fan Y (2025) Puerarin ameliorates sarcopenia in aged mice via modulation of inflammation and oxidative stress: insights from proteomics and transcriptomics. Inflammation 48:3414\u20133429","journal-title":"Inflammation"},{"key":"5971_CR23","doi-asserted-by":"crossref","unstructured":"Tao Q, Zhang J, Liang Q, Song S, Wang S, Yao X,\u00a0Gao Q, Wang L\u00a0(2023) Puerarin alleviates sleep disorders in aged mice related to repairing intestinal mucosal barrier. Nat Prod Bioprospect 13:29","DOI":"10.1007\/s13659-023-00390-3"},{"key":"5971_CR24","doi-asserted-by":"crossref","unstructured":"Xiong S, Luo J, Wang Q, Li Z, Li J, Liu Q,\u00a0Fang S, Chen T\u00a0(2021) Targeted graphene oxide for drug delivery as a therapeutic nanoplatform against Parkinson's disease. Biomater Sci 9:1705\u20131715","DOI":"10.1039\/D0BM01765E"},{"key":"5971_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12035-025-05300-x","volume":"63","author":"H Lv","year":"2025","unstructured":"Lv H, Mao N, Liu A, Zhao X, Zhu B (2025) Puerarin alleviates high-fat high-sugar diet-induced Alzheimer's disease-like pathology and insulin resistance in mice by inhibiting p35\/CDK5-mediated mitochondrial fission. Mol Neurobiol 63:9","journal-title":"Mol Neurobiol"},{"key":"5971_CR26","doi-asserted-by":"crossref","unstructured":"Ren H, Tang L, Yuan Z, Liu Y, Zhou X, Xiao X,\u00a0Wu X, Chen W\u00a0et al (2024) Combined administration of catalpol, puerarin, gastrodin, and borneol modulates the Tlr4\/Myd88\/NF-\u03baB signaling pathway and alleviates microglia inflammation in Alzheimer's disease. Front Pharmacol 15:1492237","DOI":"10.3389\/fphar.2024.1492237"},{"key":"5971_CR27","doi-asserted-by":"crossref","unstructured":"Liu S, Zhou T, Chen D, Liu R, Qin HH, Min ZL,\u00a0Liu G-Q, Cao X-L\u00a0(2021) In silico-determined compound from the root of Pueraria lobate alleviates synaptic plasticity injury induced by Alzheimer's disease via the p38MAPK-CREB signaling pathway. Food Funct 12:1039\u20131050","DOI":"10.1039\/D0FO02388D"},{"key":"5971_CR28","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1039\/C8FO01696H","volume":"10","author":"S Liu","year":"2019","unstructured":"Liu S, Cao XL, Liu GQ, Zhou T, Yang XL, Ma BX (2019) The in silico and in vivo evaluation of puerarin against Alzheimer's disease. Food Funct 10:799\u2013813","journal-title":"Food Funct"},{"key":"5971_CR29","doi-asserted-by":"publisher","first-page":"731","DOI":"10.4103\/1673-5374.230302","volume":"13","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Kong WN, Chai XQ (2018) Compound of icariin, astragalus, and puerarin mitigates iron overload in the cerebral cortex of Alzheimer's disease mice. Neural Regen Res 13:731\u2013736","journal-title":"Neural Regen Res"},{"key":"5971_CR30","doi-asserted-by":"crossref","unstructured":"Wu L, Tong T, Wan S, Yan T, Ren F, Bi K,\u00a0Jia Y\u00a0(2017) Protective effects of puerarin against A\u03b2 1-42-induced learning and memory impairments in mice. Planta Med 83:224\u2013231","DOI":"10.1055\/s-0042-111521"},{"key":"5971_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.exger.2010.09.013","volume":"46","author":"H Zhang","year":"2011","unstructured":"Zhang H, Liu Y, Lao M, Ma Z, Yi X (2011) Puerarin protects Alzheimer's disease neuronal cybrids from oxidant-stress induced apoptosis by inhibiting pro-death signaling pathways. Exp Gerontol 46:30\u201337","journal-title":"Exp Gerontol"},{"key":"5971_CR32","doi-asserted-by":"crossref","unstructured":"Ye K, Li L, Guan L, Qin MM, Xu XY, Wu J,\u00a0Huang L-Z, Gao J-J\u00a0(2025) Exploring the molecular mechanisms of Pueraria in Alzheimer's disease treatment using machine learning and network pharmacology. Front Nutr 12:1683852","DOI":"10.3389\/fnut.2025.1683852"},{"key":"5971_CR33","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ijbiomac.2021.03.032","volume":"179","author":"A Ahuja","year":"2021","unstructured":"Ahuja A, Tyagi PK, Tyagi S, Kumar A, Kumar M, Sharifi-Rad J (2021) Potential of Pueraria tuberosa (Willd.) DC. to rescue cognitive decline associated with BACE1 protein of Alzheimer's disease on Drosophila model: an integrated molecular modeling and in vivo approach. Int J Biol Macromol 179:586\u2013600","journal-title":"Int J Biol Macromol"},{"key":"5971_CR34","doi-asserted-by":"crossref","unstructured":"Koirala P, Seong SH, Jung HA, Choi JS (2018) Comparative evaluation of the antioxidant and anti-Alzheimer's disease potential of coumestrol and puerarol isolated from pueraria lobata using molecular modeling studies. Molecules 23(4):785","DOI":"10.3390\/molecules23040785"},{"key":"5971_CR35","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.apjtm.2017.10.018","volume":"10","author":"P Koirala","year":"2017","unstructured":"Koirala P, Seong SH, Jung HA, Choi JS (2017) Comparative molecular docking studies of lupeol and lupenone isolated from Pueraria lobata that inhibits BACE1: Probable remedies for Alzheimer's disease. Asian Pac J Trop Med 10:1117\u20131122","journal-title":"Asian Pac J Trop Med"},{"key":"5971_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12906-025-05154-9","volume":"25","author":"E Huh","year":"2025","unstructured":"Huh E, Kim JH, Lee S, Oh MS (2025) Interaction between rasagiline and Pueraria radix in in vitro models of Parkinson's disease. BMC Complement Med Ther 25:409","journal-title":"BMC Complement Med Ther"},{"key":"5971_CR37","doi-asserted-by":"crossref","unstructured":"Zhang X, Xiong J, Liu S, Wang L, Huang J, Liu L,\u00a0J Yang, G Zhang\u00a0et al (2014) Puerarin protects dopaminergic neurons in Parkinson's disease models. Neuroscience 280:88\u201398","DOI":"10.1016\/j.neuroscience.2014.08.052"},{"key":"5971_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/ptr.4975","volume":"28","author":"G Zhu","year":"2014","unstructured":"Zhu G, Wang X, Wu S, Li X, Li Q (2014) Neuroprotective effects of puerarin on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's disease model in mice. Phytother Res 28:179\u2013186","journal-title":"Phytother Res"},{"key":"5971_CR39","doi-asserted-by":"crossref","unstructured":"Bae N, Ahn T, Chung S, Oh MS, Ko H, Oh H,\u00a0Park G, Yang HO\u00a0(2011) The neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement in models of Parkinson's disease. J Ethnopharmacol 134:313\u2013322","DOI":"10.1016\/j.jep.2010.12.016"},{"key":"5971_CR40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s43440-024-00673-7","volume":"77","author":"NH Kim","year":"2025","unstructured":"Kim NH, Goto Y, Lee YA (2025) Effects of puerarin on gait disturbance in a 6-hydroxydopamine mouse model of Parkinson's disease. Pharmacol Rep 77:247\u2013259","journal-title":"Pharmacol Rep"},{"key":"5971_CR41","doi-asserted-by":"crossref","unstructured":"Chen T, Liu W, Xiong S, Li D, Fang S, Wu Z,\u00a0Wang Q, Chen X\u00a0(2019) Nanoparticles mediating the sustained puerarin release facilitate improved brain delivery to treat Parkinson's disease. ACS Appl Mater Interfaces 11:45276\u201345289","DOI":"10.1021\/acsami.9b16047"},{"key":"5971_CR42","doi-asserted-by":"crossref","unstructured":"Xiong S, Liu W, Li D, Chen X, Liu F, Yuan D,\u00a0Pan H, Wang Q\u00a0et al (2019) Oral delivery of puerarin nanocrystals to improve brain accumulation and anti-Parkinsonian efficacy. Mol Pharm 16:1444\u20131455","DOI":"10.1021\/acs.molpharmaceut.8b01012"},{"key":"5971_CR43","doi-asserted-by":"crossref","unstructured":"Shiying L, Xinhui Q, Guanghua J, Feng N, Feng L, Shumei C, Hu F (2018) Puerarin promoted proliferation and differentiation of dopamine-producing cells in Parkinson's animal models. Biomed Pharmacother 106:1236\u20131242","DOI":"10.1016\/j.biopha.2018.07.058"},{"key":"5971_CR44","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.neuint.2012.01.003","volume":"60","author":"G Zhu","year":"2012","unstructured":"Zhu G, Wang X, Wu S, Li Q (2012) Involvement of activation of PI3K\/Akt pathway in the protective effects of puerarin against MPP+-induced human neuroblastoma SH-SY5Y cell death. Neurochem Int 60:400\u2013408","journal-title":"Neurochem Int"},{"key":"5971_CR45","first-page":"148","volume":"23","author":"X Li","year":"2003","unstructured":"Li X, Sun S, Tong E (2003) Experimental study on the protective effect of puerarin to Parkinson disease. J Huazhong Univ Sci Technolog Med Sci = Hua zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban 23:148\u2013150","journal-title":"J Huazhong Univ Sci Technolog Med Sci = Hua zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05971-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05971-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05971-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T02:32:24Z","timestamp":1782354744000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05971-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5971"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05971-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}],"article-number":"720"}}